BONE BIOLOGICS CORP - COMMON STOCK
1.1300
07-February-25 16:45:00
15 minutes delayed
Stocks
-0.0300
-2.59%
Today's range
1.1100 - 1.1700
ISIN
N/A
Source
NASDAQ
-
Ondine Biomedical (LON:OBI) Hits New 1-Year High Following Insider Buying Activity
08 Feb 2025 13:02:11 By Buzz FX
-
Viasat's (VSAT) "Market Perform" Rating Reaffirmed at William Blair
08 Feb 2025 13:01:11 By Buzz FX
-
Under Armour (NYSE:UAA) Given "Neutral" Rating at Guggenheim
08 Feb 2025 12:51:10 By Buzz FX
-
Arrow Electronics (NYSE:ARW) Stock Rating Lowered by Bank of America
08 Feb 2025 12:46:11 By Buzz FX
-
Gov't chief keeps nation steady
08 Feb 2025 12:40:23 By Buzz FX
-
Traders Buy High Volume of Put Options on Under Armour (NYSE:UAA)
08 Feb 2025 12:21:11 By Buzz FX
-
Encompass Health (NYSE:EHC) Shares Gap Up Following Better-Than-Expected Earnings
08 Feb 2025 12:16:10 By Buzz FX
-
Algoma Steel Group Target of Unusually High Options Trading (NASDAQ:ASTL)
08 Feb 2025 12:16:10 By Buzz FX
-
FormFactor (NASDAQ:FORM) Stock Price Down 6.7% Following Analyst Downgrade
08 Feb 2025 12:16:10 By Buzz FX
-
Keefe, Bruyette & Woods Lowers BILL (NYSE:BILL) Price Target to $77.00
08 Feb 2025 12:16:10 By Buzz FX
-
WEX (NYSE:WEX) Given New $172.00 Price Target at UBS Group
08 Feb 2025 12:16:10 By Buzz FX
-
Ares Capital (NASDAQ:ARCC) Given New $23.00 Price Target at Keefe, Bruyette & Woods
08 Feb 2025 12:16:10 By Buzz FX
-
Affirm (NASDAQ:AFRM) Price Target Raised to $85.00 at JMP Securities
08 Feb 2025 12:16:10 By Buzz FX
-
Keefe, Bruyette & Woods Has Lowered Expectations for WEX (NYSE:WEX) Stock Price
08 Feb 2025 12:16:10 By Buzz FX
-
JMP Securities Reaffirms Market Perform Rating for Expedia Group (NASDAQ:EXPE)
08 Feb 2025 12:16:10 By Buzz FX
-
Sprinklr's (CXM) "Market Outperform" Rating Reiterated at JMP Securities
08 Feb 2025 12:16:10 By Buzz FX
-
Cytokinetics' (CYTK) "Market Outperform" Rating Reiterated at JMP Securities
08 Feb 2025 12:16:10 By Buzz FX
-
Boyd Gaming (NYSE:BYD) Earns "Market Perform" Rating from JMP Securities
08 Feb 2025 12:16:10 By Buzz FX
-
Prestige Consumer Healthcare (NYSE:PBH) Price Target Raised to $104.00
08 Feb 2025 12:16:10 By Buzz FX